Treatment Effectiveness
User reported effectiveness ratings Lorazepam (Ativan) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Anxiety / Nervousness | 26% | 40% | 5% | 24% | 6% | 304 |
Side Effects
User-reported side effects of Lorazepam (Ativan)
| Side Effect | Percent of Reports Lorazepam (Ativan) |
|---|---|
| Diarrhea | 3% |
| Constipation | 9% |
| Dry Mouth | 29% |
| Blurred Vision | 10% |
| Changes in Appetite | 12% |
| Changes in Sex Drive or Ability | 18% |
| Difficulty Urinating | 5% |
| Dizziness | 37% |
| Drowsiness | 70% |
| Frequent Urination | 9% |
| Making Strange Sounds | 0% |
| Restlessness or Excitement | 13% |
| Weakness | 26% |
| Weight Gain | 27% |
| Tiredness | 60% |
| Insomnia | 0% |
| Nausea | 5% |
Outcomes
Below is the degree of change seen after Lorazepam (Ativan) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Lorazepam (Ativan) Info
| Property | Value |
|---|---|
| Variable Name | Lorazepam (Ativan) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-03-18 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 94229 |